Matisse Pharmaceuticals B.V. logo

Matisse Pharmaceuticals B.V.

Matisse Pharmaceuticals B.V., a biotechnology company, develops pharmaceutical therapeutics for the treatment of sepsis..
It is developing M6229, which is in the pre-clinical phase for the treatment of severe sepsis and septic shock. The company also focuses on the research and development of therapies that neutralize cytotoxic components of the inflammatory system

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.matisse-pharma.com
Founded2014
Disease Focus
Development StagePreclinical
STOCK CODENon Listed
Address
Burgemeester P.O. box 11246160 BC Geleen
Geleen
Netherlands
Email
Contact Number
+31 88 2554 070

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]